Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
Vasograin Plus represents a major advancement in the treatment of migraine
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
cSCC is one of the most common cancers in the U.S. and globally
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Subscribe To Our Newsletter & Stay Updated
